Prognostic Value of a Three-DNA Methylation Biomarker in Patients with Soft Tissue Sarcoma

Soft tissue sarcomas (STS) are a highly aggressive and heterogeneous group of malignant mesenchymal tumors. The prognosis of patients with advanced or metastatic STS remains poor, and the main therapy of STS patients combines primary surgery, radiotherapy, and chemotherapy. Aberrant DNA methylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuxiao, Zhu, Rui, Chen, Min, Guo, Wenna, Yang, Xin, Xu, Xin-Jian, Zhu, Liucun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245661/
https://www.ncbi.nlm.nih.gov/pubmed/32508922
http://dx.doi.org/10.1155/2020/8106212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245661/
https://www.ncbi.nlm.nih.gov/pubmed/32508922
http://dx.doi.org/10.1155/2020/8106212

Ejemplares similares